Gene knockout experiments demonstrated that UBAP2L inhibition could impede cell proliferation and lead to cell cycle arrest at the G2/M phase, suggesting UBAP2L is a potential target for breast cancer treatment [19]. This evidence concerns the gene UBAP2L and breast carcinoma.